CTSF and hepatocellular carcinoma: This indicated that different threshold expression levels of CTSF may facilitate the diagnosis of early-stage NSCLC and BM, and predict the risk of BM, similar to alpha fetal protein (AFP), a biomarker widely applied for the diagnosis of hepatocellular carcinoma (HCC).